The latter exerts an effect primarily on the myocardium and is effective in infarctions and manifestations of coronary heart disease (ischemic heart disease) and is a cardiologic drug, and not nootropic, although to a small extent it has such an effect.
Lezi zinsuku zinezimpikiswano ngokuyinhloko kwi-myocardium futhi ziphumelela ekuhlukumezeni nasekuboniseni izifo zenhliziyo (ischemic disease disease) futhi imithi ye-cardiologic, hhayi i-nootropic, nakuba ngezinga elincane, inomthelela onjalo.